What is the issue size of Sai Life Sciences Ltd IPO?

The issue size of the Sai Life Sciences Ltd IPO is 30426200000.00.

What is 'pre-apply' for Sai Life Sciences Ltd IPO?

Pre-apply will allow you to apply for the Sai Life Sciences Ltd IPO 2 days before the subscription period starts.

If I pre-apply for Sai Life Sciences Ltd IPO, when will my order get placed?

Your order will be placed on the exchange as soon as the Sai Life Sciences Ltd IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Sai Life Sciences Ltd IPO order is placed?

We will notify you when your Sai Life Sciences Ltd IPO order is placed with the exchange.

What are the open and close dates of the Sai Life Sciences Ltd IPO?

Sai Life Sciences Ltd IPO will be open between 11 Dec '24 and 13 Dec '24.

What is the lot size and minimum order quantity of the Sai Life Sciences Ltd IPO?

Sai Life Sciences Ltd IPO lot size is 27 and minimum order quantity is 378.

What is the allotment date for the Sai Life Sciences Ltd IPO?

Sai Life Sciences Ltd IPO allotment date is 16 Dec '24. For Sai Life Sciences Ltd IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Sai Life Sciences Ltd IPO?

For Sai Life Sciences Ltd, the IPO registrar is KARVY. You can check Sai Life Sciences Ltd IPO allotment status on the website of the registrar.

Where is the Sai Life Sciences Ltd IPO getting listed?

The shares are proposed to be listed on the BSE and NSE.

Sai Life Sciences IPO

Sai Life Sciences Ltd

₹14,094 /27 sharesMinimum Investment

Sai Life Sciences IPO DetailsBidding DatesMin. InvestmentLot SizePrice Range
11 Dec ‘24 - 13 Dec ‘24₹14,09427₹522 - ₹549
Issue SizeIPO Doc
3042.62CrRHP PDF
Subscription rateAs of 11 Dec'24, 06:00 PM
Qualified Institutional Buyers2.61578428981228x
Non-Institutional Investor0.154634086170154x
Retail Individual Investor0.182028160499352x
Total0.84x
About Sai Life Sciences
Sai Life Sciences is a contract research, development, and manufacturing organisation (CRDMO) that caters to global pharmaceutical innovators and biotechnology companies. The company offers services spanning the entire drug discovery, development, and manufacturing process for small molecule new chemical entities (NCEs). The company’s CDMO portfolio features over 170 innovator pharmaceutical products, with 38 of these products supporting the manufacturing of 28 commercial drugs.;Founded in
1999
Managing director
Mr. Krishnam Raju Kanumuri
Parent organisation
Sai Life Sciences Ltd
Strengths & Financials of Sai Life SciencesStrengths
Risks
During FY24 and the six months ending September 30, 2024, the company served over 280 and 230 innovator pharmaceutical companies, respectively, including 18 of the top 25 global pharmaceutical companies (in terms of revenue for the calendar year 2023). Its services cater to regulated markets such as the US, UK, Europe, and Japan. 
Over the past five years and through September 30, 2024, Sai Life Sciences has supported more than 200 small molecule discovery programs. In the last three years and six months, the company has collaborated with over 160 customers.
The company claims to have implemented energy conservation initiatives in production, utilities, and effluent treatment. In FY24, it centralised air compression, installed energy-efficient pumps, and significantly increased the use of renewable energy at its Unit IV in Bidar to 89%, up from 67% in FY22, resulting in reduced carbon dioxide emissions.
Its manufacturing facilities have received certifications from major regulatory bodies, including the United States Food and Drug Administration (USFDA), Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), and India’s Central Drug Standards Control Organisation (CDSCO).
Sai Life Sciences claims to be among the few Indian CRDMOs that integrate discovery and development operations across the US, UK, and India, coupled with manufacturing capabilities located in India.
Sai Life Sciences states that the company strategically operates near key innovation clusters, with facilities in Greater Boston and Manchester. These locations provide access to cutting-edge research, a skilled global workforce, and collaboration opportunities within innovation ecosystems. Additionally, the company's facilities in India offer a cost-effective advantage, enabling large-scale drug discovery, development, and commercial production.
The company has seen a consistent increase in revenue from operations and profit after tax (PAT). Revenue from operations increased from Rs 869.59 crore in FY22 to Rs 1,217.14 crore in FY23 to Rs 1,465.18 crore in FY24. PAT increased from Rs 6.23 crore in FY22, to Rs 9.99 crore in FY23 to Rs 82.81 crore in FY24
Sai Life Sciences Financials
*All values are in Rs. Cr
No Graph Data To Display
Application Details of Sai Life Sciences IPOApply asPrice bandApply upto
Regular₹522 - 549₹2 Lakh
High Networth Individual₹522 - 549₹2 - 5 Lakh
For Sai Life Sciences IPO, eligible investors can apply as Regular.

Bidding Dates	Min. Investment	Lot Size	Price Range
11 Dec ‘24 - 13 Dec ‘24	₹14,094	27	₹522 - ₹549

Issue Size	IPO Doc
3042.62Cr	RHP PDF

Apply as	Price band	Apply upto
Regular	₹522 - 549	₹2 Lakh
High Networth Individual	₹522 - 549	₹2 - 5 Lakh

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

ABOUT GROWW

Groww is India’s No.1 Stock Broker and Trading Platform with more than 1 crore active customers where users can find their investment solutions pertaining to mutual funds, stocks, US Stocks, ETFs, IPO, and F&Os, to invest their money without hassles.

Groww objectively evaluates stocks and mutual funds and does not advise or recommend any stocks, mutual funds or portfolios. Investors shall invest at their own discretion, will and consent. Groww, at any time, does not guarantee fixed returns on the capital invested.

Groww helps investors -

· By providing 100% paperless online free Demat and trading account opening

· By providing an objective evaluation of products available on the platform

· By being transparent about fees and charges involved while investing in a product

· By offering decision-making assistance by providing technical analysis with advanced charts, well-designed line & candlestick charts that indicate share price movements, and market indices, along with more details about all registered and listed companies

SECURE TRANSACTIONS ON GROWW

All transactions on Groww are safe and secure. Users can invest through SIP or Lumpsum using Netbanking through all supported banks. It uses BSE Star MF (with Member code 11724) as transaction platform.

TRADE AND INVEST SECURELY WITH GROWW

Stocks, Mutual fund investments, F&Os, etc., are very popular with individual investors because of their numerous benefits. On Groww, an investor can -

- Invest in Nifty 50 (NSE) & Sensex (BSE) listed stocks

- Diversify across multiple stocks and other instruments

- Start SIP with any amount (as low as Rs. 500)

- Switch regular funds to direct funds

- Start automated monthly investments (SIP), and benefit from many more features

All type of mutual funds are available on Groww.

INVESTING IN MUTUAL FUND PORTFOLIOS

Portfolio is collection of mutual funds designed to meet your investment goals. Investing in mutual fund portfolios helps you in diversifying your investments and reduces the risk. Portfolios also help you in assigning an investment goals and make it easy for you to save for and achieve your goals. You can create a portfolio yourself or ask an expert to build it for you.

ATTENTION INVESTORS

1. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.

2. For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.

3. KYC is a one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

4. If you are subscribing to an IPO, there is no need to issue a cheque. Please write the Bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non allotment the funds will remain in your bank account.

· Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

· Awareness regarding guidelines on Margin collection

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Issued in the interest of Investors

DISCLAIMER

Groww Invest Tech Pvt. Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) (CIN: U65100KA2016PTC092879) is a member of NSE & BSE with SEBI Registration no: INZ000301838, Depository Participant of CDSL Depository with SEBI Registration no: IN-DP-417-2019 and Mutual Fund distributor with AMFI Registration No: ARN-111686. Registered office and Correspondence office - No.11, 2nd floor, 80 FT Road, 4th Block, S.T Bed, Koramangala, Bengaluru – 560034. For any grievances related to Stock Broking/DP, please write to [email protected] , please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Groww Invest Tech Pvt. Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Unless otherwise specified, all returns, expense ratio, NAV, etc are historical and for illustrative purposes only. Future will vary greatly and depends on personal and market circumstances. The information provided by our blog is educational only and is not investment or tax advice.

Mutual fund investments are subject to market risks. Please read all scheme related documents carefully before investing. Past performance of the schemes is neither an indicator nor a guarantee of future performance.

Terms and conditions of the website/app are applicable. Privacy policy of the website is applicable.

Qualified Institutional Buyers	2.61578428981228x
Non-Institutional Investor	0.154634086170154x
Retail Individual Investor	0.182028160499352x
Total	0.84x